Oxycyte
OX-CL-II-005
Phase 2 small_molecule terminated
Quick answer
Oxycyte for Traumatic Brain Injury is a Phase 2 program (small_molecule) at TENAX THERAPEUTICS, INC. with 2 ClinicalTrials.gov record(s).
Program details
- Company
- TENAX THERAPEUTICS, INC.
- Indication
- Traumatic Brain Injury
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated